CHMP5: Key Regulator of Cellular Signaling Pathways (G51510)

Target Name: CHMP5

NCBI ID: G51510

CHMP5

CHMP5: Key Regulator of Cellular Signaling Pathways

CHMP5, also known as C9orf83, is a protein that is expressed in most tissues of the body. It is a key regulator of gene expression and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of CHMP5 is its role in regulating the expression of genes that are involved in cell signaling pathways, such as the signaling pathways that are responsible for cell growth, differentiation, and survival. CHMP5 has been shown to play a key role in the regulation of the PI3K/Akt signaling pathway, which is involved in a wide range of cellular processes, including cell growth, migration, and survival.

In addition to its role in regulating gene expression, CHMP5 has also been shown to play a key role in the regulation of cellular signaling pathways. For example, CHMP5 has been shown to play a key role in the regulation of the TGF-β signaling pathway, which is involved in the regulation of cell growth, differentiation, and survival.

CHMP5 has also been shown to play a key role in the regulation of cellular immune responses. For example, CHMP5 has been shown to play a key role in the regulation of the development and function of natural killer cells, which are a critical part of the immune system and are involved in the regulation of cell death and survival.

In addition to its role in regulating cellular signaling pathways, CHMP5 has also been shown to play a key role in the regulation of gene expression in cancer cells. For example, CHMP5 has been shown to play a key role in the regulation of the expression of genes that are involved in the development and progression of cancer.

Overall, CHMP5 is a protein that has a wide range of functions in the regulation of cellular signaling pathways, including the PI3K/Akt and TGF-β signaling pathways. Its role in these processes makes it an attractive target for drug development, particularly for the treatment of diseases associated with these signaling pathways, such as cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, CHMP5 is also a potential biomarker for a number of diseases. For example, CHMP5 has been shown to be expressed in a wide range of tissues and has been used as a biomarker for a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, CHMP5 is a protein that has a wide range of functions in the regulation of cellular signaling pathways, including the PI3K/Akt and TGF-β signaling pathways. Its role in these processes makes it an attractive target for drug development, particularly for the treatment of diseases associated with these signaling pathways. In addition to its potential as a drug target, CHMP5 is also a potential biomarker for a number of diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: Charged Multivesicular Body Protein 5

Functions: Probable peripherally associated component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses) (PubMed:14519844). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Involved in HIV-1 p6- and p9-dependent virus release (PubMed:14519844)

The "CHMP5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHMP5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets